Literature DB >> 11798132

Regulation of IL-5 expression.

V A Mordvinov1, C J Sanderson.   

Abstract

Interleukin 5 (IL-5) is a cytokine primarily involved in the pathogenesis of atopic diseases. It specifically controls the production, activation and localization of eosinophils, the major cause of tissue damage in atopic diseases. IL-5 belongs to a gene family shared by IL-3, IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF) and is predominantly regulated at the transcriptional level. A variety of stimuli and modulators have been identified as regulating production of IL-5 both in vivo and in vitro, indicating a highly complex series of control mechanisms. However, a better understanding of the biology of IL-5 and the regulation of its expression is crucial for the development of new therapeutic agents for allergic disease. This review covers the major molecular aspects of IL-5 research.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11798132

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  3 in total

1.  Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety.

Authors:  Anna-Barbara Moscicki; Rupert Kaul; Yifei Ma; Mark E Scott; Ibrahim I Daud; Elizabeth A Bukusi; Stephen Shiboski; Anuradha Rebbapragada; Sanja Huibner; Craig R Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2012-02-01       Impact factor: 3.731

2.  Strain-dependent release of cytokines modulated by Lactobacillus salivarius human isolates in an in vitro model.

Authors:  Lorenzo Drago; Lucia Nicola; Enrico Iemoli; Giuseppe Banfi; Elena De Vecchi
Journal:  BMC Res Notes       Date:  2010-02-25

3.  NFκB attenuates IL-5 production and upregulates T-box transcription factors in Th2-like T cells.

Authors:  Masaaki Hashiguchi; Ayano Kobayashi; Yuji Kashiwakura; Hidefumi Kojima; Yumiko Kanno; Akira Kurosu; Shogo Tokudome; Tetsuji Kobata
Journal:  Cytotechnology       Date:  2013-08-11       Impact factor: 2.058

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.